The Middle EAST Viral Inactivation Market was valued at USD 0.75 billion in 2024 and is projected to reach USD 1.50 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of viral infections, heightened regulatory scrutiny, and the growing demand for safe and effective therapeutic solutions. The rising...

The solvent-detergent method has long been a cornerstone for securing the safety of plasma-derived products, such as albumin and clotting factors. This chemical process involves adding specialized agents like tri-n-butyl phosphate and Triton X-100 to disrupt the lipid bilayer of enveloped viruses. In late 2025, the development of sustainable, biodegradable detergents is allowing manufacturers...